Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile.
van der Valk M, Kastelein JJ, Murphy RL, van Leth F, Katlama C, Horban A, Glesby M, Behrens G, Clotet B, Stellato RK, Molhuizen HO, Reiss P; Atlantic Study Team.
van der Valk M, et al. Among authors: stellato rk.
AIDS. 2001 Dec 7;15(18):2407-14. doi: 10.1097/00002030-200112070-00008.
AIDS. 2001.
PMID: 11740191
Clinical Trial.